PMFA
PBYI icon

Plante Moran Financial Advisors’s Puma Biotechnology PBYI Stock Holding History

Plante Moran Financial Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,000
Closed -$59K – 827
2018
Q2 		$59K Buy
1,000
+600
+150% +$34.8K 0.03% 300
2018
Q1 		$27K Sell
400
-100
-20% -$7.49K 0.01% 456
2017
Q4 		$49K Hold
500
– – 0.03% 352
2017
Q3 		$60K Sell
500
-500
-50% -$46.5K 0.04% 270
2017
Q2 		$87K Sell
1,000
-500
-33% -$28K 0.05% 222
2017
Q1 		$56K Buy
1,500
+1,000
+200% +$36.5K 0.03% 296
2016
Q4 		$15K Sell
500
-300
-38% -$13K 0.01% 523
2016
Q3 		$54K Sell
800
-700
-47% -$35.4K 0.04% 301
2016
Q2 		$45K Buy
+1,500
New +$46.9K 0.03% 305

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return